THE COMPANY Cumberland Pharmaceuticals Inc. ("Cumberland," the "Company," or as used in the context of "we," "us" or "our"), is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceuticals. We are dedicated to our mission of working together to provide unique products that improve the quality of patient care. Our primary target markets are hospital acute care, gastroenterology and oncology. These medical specialties are ...
Q2 FY2026 — expected 2026-08-05
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-09 | 2025-12-31 | 0001087294-26-000020 | EDGAR | 62K words |
| 2025-03-07 | 2024-12-31 | 0001628280-25-011366 | EDGAR | — |
| 2024-03-13 | 2023-12-31 | 0001628280-24-010725 | EDGAR | — |
| 2023-03-13 | 2022-12-31 | 0001628280-23-007727 | EDGAR | — |
| 2022-03-11 | 2021-12-31 | 0001628280-22-005942 | EDGAR | — |
| 2021-03-12 | 2020-12-31 | 0001628280-21-004654 | EDGAR | — |
| 2020-03-20 | 2019-12-31 | 0001628280-20-003880 | EDGAR | — |
| 2019-03-12 | 2018-12-31 | 0001628280-19-002785 | EDGAR | — |
| 2018-03-09 | 2017-12-31 | 0001628280-18-003034 | EDGAR | — |
| 2017-03-13 | 2016-12-31 | 0001628280-17-002485 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-07 | 2025-09-30 | 0001087294-25-000020 | EDGAR | 17K words |
| 2025-08-08 | 2025-06-30 | 0001628280-25-039326 | EDGAR | — |
| 2025-05-09 | 2025-03-31 | 0001628280-25-024342 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001628280-24-046730 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0001628280-24-036529 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001628280-24-022658 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001628280-23-038418 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0001628280-23-029112 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001628280-23-017951 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001628280-22-029906 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001628280-22-022735 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0001628280-22-014372 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-03 | 0001087294-26-000015 | EDGAR | 6K words |
| 2026-02-04 | 0001087294-26-000011 | EDGAR | — |
| 2025-11-24 | 0001087294-25-000023 | EDGAR | — |
| 2025-11-04 | 0001087294-25-000017 | EDGAR | — |
| 2025-10-21 | 0001087294-25-000012 | EDGAR | — |
| 2025-08-05 | 0001628280-25-037923 | EDGAR | — |
| 2025-05-06 | 0001628280-25-022753 | EDGAR | — |
| 2025-04-28 | 0001628280-25-020222 | EDGAR | — |
| 2025-03-19 | 0001628280-25-013875 | EDGAR | — |
| 2025-03-04 | 0001628280-25-009967 | EDGAR | — |
332 total filings indexed. 300 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001087294 |
| Ticker | CPIX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | TN |
| Website | https://www.cumberlandpharma.com |
| Listed | 2009-08-11 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report